Inventor
GUANGWEI HE
Inventor
CN
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes25%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry13%
C07DHeterocyclic compounds13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
PatentTitleYear
11,572,359PARP/PI3K double-target inhibit containing pyridopyrimidine structure202311,318,151Compound pharmaceutical composition for treating skin inflammatory diseases202211,161,860Compound having effects of inhibiting phosphodiesterase 4, preparation method thereof and pharmaceutical use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to HEFEI INDUSTRIAL PHARMACEUTICAL INST CO LTD (3)· patent assignee history
2021–2022Patents assigned to HEFEI AMVITE PHARMACEUTICAL CO LTD (2)· patent assignee history
2021–2023Based in CN· patent location history
2023Patents assigned to UNIV CHINA PHARMA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HEFEI INDUSTRIAL PHARMACEUTICAL INST CO LTD | 3 | 2021–2023 |
| HEFEI AMVITE PHARMACEUTICAL CO LTD | 2 | 2021–2022 |
| UNIV CHINA PHARMA | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 3 | 2021–2023 |